Chemosyn Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1962PLC012310 Incorporated 27 March 1962 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2025
₹24.95 Cr
▼ 22% YoY
Net loss · FY 2025
₹19,214
Net margin 0%
EBITDA · FY 2025
₹73.65 Lakh
EBITDA margin 3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹4.51 Cr
Satisfied ₹8.35 Cr
Company age
64 yrs
Est. 1962
Directors on board
3
As per MCA filings

About Chemosyn Limited

Data last updated:

Chemosyn Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 1962 and has been in existence for over 64 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1962PLC012310. Its GSTIN is 27AAACC2044D1ZA (Maharashtra). The company holds 13 GST registrations, of which 11 are active.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was formerly known as Chemosyn Private Limited. It is led by directors including Kanhai Samir Shah (Managing Director) and Aanal Samir Shah (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹24.95 Cr, a decline of 22% compared to the previous year. For the same year it recorded a net loss of ₹19,214 (net margin 0%) and EBITDA of ₹73.65 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 9% over five years.

The company is associated with 1 brand: Chemosyn. As per MCA filings, the company has open charges of ₹4.51 Cr and satisfied charges of ₹8.35 Cr on record. Court records list 38 cases involving the company, including 19 filed by the company and 14 filed against it; 3 cases are pending. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Healkraft Pharma (India) Private Limited with revenue of ₹25.01 Cr. The company has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers.

Chemosyn Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0112818). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website chemosynltd.com.

Company Details of Chemosyn Limited
CIN U24239MH1962PLC012310
Registration Number 012310
Incorporation Date 27 March 1962
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0112818

Recognitions & Rankings of Chemosyn

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-01-0112818
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    Akshay Mittal Indl. Premises Cs Ltd Sanjay Bldg. No.5 B Unit No.46 Ground Flr. Andheri, (E), Mumbai, Maharashtra, India – 400059
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Chemosyn Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Chemosyn Limited report

Financials, compliance, directors, charges, ownership and filings for Chemosyn Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

Associated Brands with Chemosyn Limited

Chemosyn operates one associated brand: Chemosyn. Each brand links to its own profile.

BrandDescriptionWebsite
Pharmaceutical manufacturing and distribution of medicines in India.chemosynltd.com

Business Activity of Chemosyn Limited

The main business activity of Chemosyn is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical productsLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Chemosyn Limited FY 2025 filings available

Chemosyn Limited reported revenue of ₹24.95 Cr (down 22% YoY) for FY 2025.

Revenue · FY 2025
₹24.95 Cr ▼ 22%
Net loss · FY 2025
₹19,214 margin 0%
EBITDA · FY 2025
₹73.65 Lakh margin 3%

Compounded Annual Growth Rate (CAGR) of Chemosyn Limited

Revenue CAGR growth
1 year
▼ 22%
3 years · compounded
▼ 11%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 1%
5 years · compounded
▼ 13%

Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 22% fall in the latest year. EBITDA fell 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Chemosyn Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations••••••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹73.65 Lakh••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹19,214••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Chemosyn Limited

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin3%••••••••••••••••
Net Profit Margin0%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Chemosyn are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Chemosyn Limited

Chemosyn has 3 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Aanal Samir ShahWhole-Time Director18 Jul 200620 Years 3 MonthsCurrent
Kanhai Samir ShahManaging Director13 Dec 200718 Years 10 MonthsCurrent
Madhav Samir ShahDirector13 Dec 200718 Years 10 MonthsCurrent

Peer Comparison of Chemosyn Limited

Chemosyn Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Healkraft Pharma (India) Private Limited₹25.01 Cr (FY 2025)••••••••-1.0%••••Chennai, Tamil Nadu, India
U Square Lifescience Private Limited₹24.98 Cr (FY 2024)••••••••-25.0%••••Tal Sarkhej Ahmedabad Ii, Gujarat, India
Amulya Herbs Private Limited₹24.97 Cr (FY 2024)••••••••20.0%••••Chandigarh, India
Anthus Pharmaceuticals Private Limited₹24.97 Cr (FY 2024)••••••••4.0%••••Chennai, Tamil Nadu, India
Biovitamins Private Limited₹24.97 Cr (FY 2025)••••••••35.0%••••Bangalore, Karnataka, India
Chemosyn Limited this company₹24.95 Cr (FY 2025)••••••••-22.0%••••Mumbai, Maharashtra, India
Thrift Pharmaceuticals Private Limited₹24.95 Cr (FY 2024)••••••••11.0%••••Vadodara, Gujarat, India
Eucare Pharmaceuticals P Ltd₹24.93 Cr (FY 2024)••••••••31.0%••••Tamil Nadu, India
Pyxus Pharmaceuticals Private Limited₹24.91 Cr (FY 2025)••••••••-4.0%••••Ahmedabad, Gujarat, India
Artura Pharmaceuticals Private Limited₹24.89 Cr (FY 2024)••••••••37.0%••••Chennai, Tamil Nadu, India
Greentech Laboratories Private Limited₹24.88 Cr (FY 2025)••••••••7.0%••••Srikakulam, Andhra Pradesh, India

Peers are the five companies nearest above and the five nearest below Chemosyn by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Auditor Details of Chemosyn Limited

Chemosyn Limited is audited by SAMIR M. SHAH & ASSOCIATES. for the financial year 2023.

NameStatusAppointment DateCessation Date
SAMIR M. SHAH & ASSOCIATES.LockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Chemosyn Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Chemosyn Limited

Open charges
₹4.51 Cr
Satisfied charges
₹8.35 Cr
Breakdown by lending institutions
The Kalupur Commercial Co-Operative Bank Limited₹4.51 Cr
Latest charge details
DateLenderAmountStatus
17 Sep 2025The Kalupur Commercial Co-Operative Bank Limited₹13 LakhOpen
17 Sep 2025The Kalupur Commercial Co-Operative Bank Limited₹72 LakhOpen
11 Feb 2010The Kalupur Commercial Co-Operative Bank Limited₹1.25 CrOpen
09 Feb 2010The Kalupur Commercial Co-Operative Bank Limited₹2.41 CrOpen
07 Dec 2016Others₹70 LakhSatisfied

Total charge records: 9 View all charges

Deals & Funding of Chemosyn Limited

Chemosyn Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018.

Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹83.7 Lakh

Deals on record (2 of 2)

WhenDealAmountParties
Sep 2018Secondary share transferUndisclosedBuyer: an individual
Seller: an individual
Mar 2008Funding round₹83.7 LakhInvestors: Ramdoot Intratrade LLP, Mahabali Intratrade LLP , 2 individuals
Premium access

Full deal history

All 2 deals with amounts, valuations, instruments and every party are in the company report.

  • Every funding round and share transfer
  • Amounts and valuations
  • Investors, buyers and sellers
  • Instruments and deal dates

Verified entity values are shown only after access is granted.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

MSME Payment Delays by Chemosyn Limited

Chemosyn Limited has 8 MSME Form 1 returns on record between 2018 and 2024, listing 33 overdue payments to 10 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 10)

SupplierAmount dueDue sinceReported on
Laxmi Print Art••••••••••••
Omkar Traders••••••••••••
an individual supplier••••••••••••
Futuristic Packaging Private Limited••••••••••••
an individual supplier••••••••••••
Premium access

Full MSME payment history

Every supplier, amount and due date from all 8 MSME Form 1 returns is in the company report.

  • Every reported supplier due
  • Amounts and due dates
  • Reasons given in each return
  • Period-by-period history

Verified entity values are shown only after access is granted.

Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.

Employees and EPFO Compliance at Chemosyn Limited

Employment history and EPFO contributions of people linked to Chemosyn.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Chemosyn Limited

Chemosyn Limited has 8 board changes on record since 2006: 3 appointments and 5 cessations. The latest: Aanal Samir Shah ceased to be Director on 04 Apr 2011.

AGM
Chemosyn Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited of Rs. 2.41 Cr registered on 09 Feb 2010 with Charge ID 10208728 was modified on 22 Sep 2025.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 0.13 Cr with Charge ID 101166594 was registered on 17 Sep 2025.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited amounted to Rs. 0.72 Cr with Charge ID 101166673 was registered on 17 Sep 2025.
Charges
A charge with The Kalupur Commercial Co-Operative Bank Limited of Rs. 1.25 Cr registered on 11 Feb 2010 with Charge ID 10208727 was modified on 17 Sep 2025.
Filing
Chemosyn Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge registered on 19 Apr 2010 via Charge ID 10216602 with The Kalupur Commerical Co-Operative Bank Limited was fully satisfied on 26 May 2022.
Charges
A charge registered on 07 Dec 2016 via Charge ID 100066257 with Others was fully satisfied on 09 Mar 2022.
Charges
A charge registered on 27 Aug 2015 via Charge ID 10587721 with The Kalupur Commercial Co-Operative Bank Limited was fully satisfied on 10 Dec 2020.
Charges
A charge registered on 12 Nov 2012 via Charge ID 10387606 with The Kalupur Commercial Co-Op. Bank Ltd. was fully satisfied on 21 Mar 2018.
Charges
A charge with Others amounted to Rs. 0.70 Cr with Charge ID 100066257 was registered on 07 Dec 2016.
Charges
A charge with The Kalupur Commercial Co-Op. Bank Ltd. of Rs. 0.90 Cr registered on 12 Nov 2012 with Charge ID 10387606 was modified on 21 Sep 2015.

17 earlier events are listed in the company report.

Credit Ratings, Litigation & Regulatory Alerts for Chemosyn Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Chemosyn Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Chemosyn Limited

Chemosyn has 13 GST registrations: 11 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
13
Active
11
Cancelled / inactive
2
GSTINStateStatusRegistered on
27AAACC2044D1ZAMaharashtraActive01 Jul 2017
04AAACC2044D1ZIChandigarhActive01 Jul 2017
08AAACC2044D1ZARajasthanActive01 Jul 2017
09AAACC2044D1Z8Uttar PradeshActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Chemosyn Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chemosyn Limited

Chemosyn is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 1962 (64+ years old) and is registered under CIN U24239MH1962PLC012310.

Chemosyn reported revenue of ₹24.95 Cr for FY 2025 (down 22% YoY).

Chemosyn has 3 current directors:

Chemosyn reported a net loss of ₹19,214 (net margin 0%) and EBITDA of ₹73.65 Lakh (EBITDA margin 3%) for FY 2025, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Chemosyn is -11% over three years and -9% over five years. In the latest year (FY 2025) revenue fell 22%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Chemosyn is 27AAACC2044D1ZA, registered in Maharashtra. The company has 13 GST registrations in all, of which 11 are active and 2 are cancelled or inactive. Other active GSTINs include 04AAACC2044D1ZI (Chandigarh), 08AAACC2044D1ZA (Rajasthan), 09AAACC2044D1Z8 (Uttar Pradesh).

The CIN (Corporate Identification Number) of Chemosyn is U24239MH1962PLC012310. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Chemosyn has 38 court cases on record: 19 filed by the company and 14 filed against it. 3 are pending. Most are in the high courts.

Chemosyn was incorporated on 27 March 1962, making it 64+ years old. It is registered with the Registrar of Companies, Mumbai.

Chemosyn has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹83.7 Lakh; the latest was in September 2018.

The peers of Chemosyn by revenue are Healkraft Pharma (India) Private Limited, U Square Lifescience Private Limited, Amulya Herbs Private Limited, Anthus Pharmaceuticals Private Limited, Biovitamins Private Limited and 5 more, all in the Pharma industry (Formulations).

Aanal Samir Shah ceased to be Director on 04 Apr 2011. Arvind Balu Thakkar ceased to be Director on 21 Jul 2009. Kanhai Samir Shah ceased to be Additional Director on 27 Sep 2008. Chemosyn has 8 board changes on record in total.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available